Most microbes live in heterogeneous, multi-species communities in close association with each other. Microbial consortia are dynamic, interacting communities of two or more microbial groups. Synergistic interspecies associations can provide complex functional capabilities to the consortium, far greater than that achievable with monocultures (1). Biofilms are surface-associated, structured, multi-species microbial consortia that colonize a wide range of substrates of medical importance, posing a serious clinical and public health concern (2). There is an imperative need for innovative strategies to overcome biofilm resistance. Harnessing the potential of individual cell populations and their interactions could serve as a novel therapeutic approach to combat antibiotic resistance in biofilms.
We used a combination of biological experiments and quantitative, physics-based analysis and modeling to describe how the efficacy of antibiotics is altered by changes in the environment. Such changes in the environment can be caused by the bacterial population itself and by external manipulation.
Here are the papers we published on this: https://royalsocietypublishing.org/doi/10.1098/rsif.2015.0018 https://www.nature.com/articles/npjbiofilms20166